Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Im not sure what's worse for you claiming nonsense without any source or claiming nonsense and directing to some imaginary source thinking that anyone here will actually go and look where you say something is supposed to be and then claiming you proved your point. We had this conversation ooh I dont know 10-15 times?
Maybe I will try your tactic in court by just claiming some evidence is somewhere on the internet, perhaps the judge will believe me lol.
Come to think of it already made that joke like 2 or 3 times already. Help Im stuck in a never-ending post loop with exwannabe
I have given up asking ex actually substantiating any of his claims.
exactly
nothing that has been said by her can be construed to any trial or treatment that may or may not be available soon or in the future.
She was talking about the progress of preservation and analyzing tumor tissue in the years to come given the fact that in the past 20 years it has dramatically improved. If in one year from now DCVAX L were to be approved would it not be great to have the preservation and analyzing of tumor tissue progressed and improved in the years to come? Of course, it would, it would help the patient receiving DCVAX L dramatically.
There has been talking about the importance of GBM tissue being preserved within the academic world for many years now, in that regard, there is nothing new that she said that can be linked to the DCVAX trial good or bad.
https://pubmed.ncbi.nlm.nih.gov/31087206/
anyone making any conclusion about this in regard to the DCVAX L trial is gravely mistaking
I think it’s kind of best to have all options available because of how we kind of analyze and preserve tissues today may be different from what it is five years from now.
Next is she says 'Save your resected tumor, make DcVaxL vaccine and take it wherever you are in the world!'
thank your powerwalker its heartwarming that you think of me and my son when you saw that article. Bless you and your family Thanks!
yes I read it Im also invested in anavex and my son is in the spectrum of autism. So I was very excited about that news. Thank you for sharing
If NWBO will obtain a MC of 20 billion anavex will of x10 that IMO
JAMA did not reject the publication. Biogen withdrew the publication from JAMA and decided to pursue other publication opportunities."
The pertinent points are that one, most drug companies publish clinical trial results in a peer reviewed journal BEFORE obtaining FDA approval; and two, the drug companies do not comment on what might be happening with the publications.
Reverse splits are not investor friendly. Share buybacks are investor friendly!
you all dont know what Italian food really is until you have visited
Emilia Romagna and of course Sicily.
lol I hear you flipper I am annoyed as much by bears as by NWBO groupies.
Like you I choose to live in reality.
the only way to value a company is on future cash flow, not fantasy assumptions. If Direct were to be approved for all solid cancers and the FDA and NWBO have withstood the lawsuits that would undoubtedly follow for that approval, then we can talk. Until then it's fantasy.
that is some wisdom you have my friend. I hope your investment will be rewarded soon!
fully agree especially those about Tesla and Amazon validations absurd.
ooh please people this is getting ridiculous and absurd.
NWBO will be sold for around 22-23B that's around 16$ a share and that will be that.
If you bought a million shares at 25 cents what more do you want than that?
anything else here is fantasy
jeez
FYI - Common Shareholders are not considered supporters.
Good point PM. NWBO is already selling its shares at a12%discount post trial date. What is that signaling to the market?
yes very distasteful I must say
the EMA approving and FDA disapproving has happend with Galapago's Filgotinib as well
same we will see with Biogen's aducanumab FDA thumbs up EMA hard no wait and see..
gary we sometimes forgot that this is an adaptive trial.
I believe NWBO has gone through every step in coordination with the FDA and therefore the approval may not take long at all. Just what I think
You really are feeling the reality that you know your investment is toast
The joke is you have apparently not read the conditions of the structure of the loan deal. The lenders could, as we have seen for example in the May loan, have optioned for many other rewards for providing the loan such as interest on the due date, but they did not. Why is that? Apparently, they are willingly risking to pass on their reward for the loan and the repayment of the principal amount itself if the trial results are not good and partially forfeit the reward of the loan if trial results are not in before Nov 1. Why is that? These lenders are not stupid they must have been told very positive trial results are in before Nov 1 otherwise they would just pass on a part of their reward and risk losing the principal amount. Of course, the lenders know the trial results are good and most likely in before Nov 1.
Additionally, NWBO has to find the amount due in 2 months from now if they have not disclosed trial results before Nov 1.
Hey Vubru,
Its good to see you here again.
thank you very much for your response. You have lifted my mood again
Flipper said this already. This study outcome is highly anticipated so I presume a lot of journals will prioritize this especially NEJM where they have previously published.
And I can't imagine this would not have been submitted either.
thanks
[
Ha and there is that yes
No private placements until clinical data release
After a first submission, [it takes] 2 to 3 months to have a first response. [It's] rarely positive straight away so 2, maximum 3 corrections rounds [that takes] 4 to 6 months.
Once accepted, the publication itself depends on the journal process and the relevance/importance of the paper.
Around 9 months to 1 year is not unusual.
meanwhile, the stock market is breaking record after record after record
after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record afterrecord after record after
But Im still happy I put most of my money in NWBO yippie ahum lol
thanks sojo
Im guessing you trade US-CAD dollars? lol
I don't think they can sell any shares until AFTER clinical trial data release, so there's that.
But the angels can and likely will continue to loan small amounts of money until they release the data, although everyone likely wants to keep those loans to a minimum.
And I can see that you're sticking with only 20 to 25 million shares as being available with the insider warrants and options tied up.
what can I say
Im an incredibly optimistic person by nature so every day I have new hope.
Hi Senti,
Just got back from a few days. Thank you for answering.
Thanks
And thank you for all your posts, I would have left the building already if it wasnt for your posts and some other posters like Senti
No one knows when/if a paper has been submitted unless they are on the inside
what an incredible depression post
I agree with you on that
whiskey sour yum indeed lol Im going to have one right now and toast on all your good health and good fortune cheers.
lol
thanks, PM. for the life of me, I cannot imagine LP going to be that stubborn to rather not disclose TLD for it was somehow not perfect enough as to how she planned it, and risk the company sink to the bottom of the ocean, then to just release an imperfect dataset and safe NWBO.
With each day passing without TLD I will be drinking as well. My prefered poison of choice Jenever
LP can always do what she did in late 2018(?) and sell preferred share where the convert feature was restricted until they took care of the share limit issues.
No one can explain how they are able to afford November let alone December without TLD. Impossible. Half Oct through dec they will be needing 12 million cash, so how? I have another bet. If on Nov 1 no TLD I see a filing for bankruptcy following soon after.
The 20 million shares left won't cut it or they have to break some rules. An at-the-market offering is at its stand now not permitted but Im not 100% about that and Im pretty sure no one wants to lend that amount of money.
Even if an ATM sale of the 20 million is possible at let's say then 50 - 70 cents (SP tanking if no TLD after Nov 1) then they have no more shares for after TLD. Let alone to get into 2022.
In other words, delaying TLD any further after Nov 1 is IMO with all the loans that need to be repaid and the operational cash p/m of 3.2 million, begging for bankruptcy.